Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study
Wang X, Zhang Y, Hou W, Wang Y, Zheng J, Li J, Lin L, Jiang Y, Wang S, Xie Y, Zhang H, Shu Q, Li P, Wang W, You J, Li G, Liu J, Fan H, Zhang M, Lin H · Chinese Journal of Integrative Medicine · 2019 August 31
DOI 10.1007/s11655-019-3168-6
Objective
To evaluate the association between Chinese medicine (CM) therapy and disease-free survival (DFS) outcomes in postoperative patients with non-small cell lung cancer (NSCLC).
Conclusions
Longer duration of CM therapy could be considered a protective factor of cancer recurrence and metastasis. CM treatment is associated with improving survival outcomes of postoperative NSCLC patients in China.
Critical Appraisal
Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.
This article has not yet been critically appraised by the Research Hub.
Learn more about Critical Appraisal
